TSO3 announces the Vote Results from its Annual Meeting of the Shareholders

QUÉBEC CITY, May 11, 2017 /CNW Telbec/ - TSO3 Inc. (TSX: TOS), an innovator in sterilization technology for medical devices in healthcare settings, today announced that the nominees listed in the management proxy circular dated April 4, 2017, were elected as directors of TSO3. In addition, all other proposals submitted by management were approved.

Election of Directors

Based on the proxies received and the votes on a show of hands, the following individuals were elected as directors of the Corporation until the next annual shareholders' meeting. Accordingly, the results are set out below:

 

 

Name

 

Votes for

 

% for

Votes
against

%
against

 

Withheld

 

% withheld

Germain Carrière

31,583,349

86.21

0

0

5,053,411

13.79

Pierre Désy

36,616,660

99.95

0

0

20,100

0.05

Jean Lamarre

36,602,792

99.91

0

0

33,968

0.09

Claude Michaud

36,605,792

99.92

0

0

30,968

0.08

Jeffrey Pompeo

36,594,567

99.88

0

0

42,193

0.12

Jean-Pierre Robert

36,605,192

99.91

0

0

31,568

0.09

Linda Rosentstock

36,591,224

99.88

0

0

45,536

0.12

Richard M. Rumble

36,604,067

99.91

0

0

32,693

0.09

Steve West

36,597,424

99.89

0

0

39,336

0.11

 

Other Proposals

 

Appointment of
Independent Auditors

 

41,664,774

 

99.91

 

0

 

0

 

39,404

 

0.09

Amendment of the
Company's 2016 Stock
Incentive Compensation
Plan

 

 

25,569,212

 

 

 

69.79

 

 

11,067,548

 

 

30.21

 

 

0

 

 

0.00

 

Final voting results on all matters voted at the Annual Meeting of Shareholders held on May 10, 2017, will be filed on SEDAR (www.sedar.com) under the name TSO3.

About TSO3

Founded in 1998, TSO3's activities encompass the sale, production, maintenance, research, development and licensing of sterilization processes, related consumable supplies and accessories for heat-sensitive medical devices. The Company designs products for sterile processing areas in the hospital environment that offer an advantageous replacement solution to other low temperature sterilization processes currently used in hospitals. TSOalso offers services related to the maintenance of sterilization equipment and compatibility testing of medical devices with such processes.

For more information about TSO3, visit the Company's website at www.tso3.com         

 

SOURCE TSO3 Inc.

For further information: Company Contacts: TSO3 Inc., R.M. (Ric) Rumble, President and CEO, Tel: 418 651-0003, Email: info@tso3.com; TSO3 Inc., Glen Kayll, CFO, Tel: 418 651-0003, Email: info@tso3.com; Investor Relations: Capital Market Access LLC, Ron Both, 949 432-7557, courriel: tos@cma.team; Renmark Financial Communications Inc., Barry Mire, Tel: 416 644-2020 or 514 939-3989, Email: bmire@renmarkfinancial.com

RELATED LINKS
http://www.tso3.com

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890